These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16799074)

  • 1. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.
    Hurst JR; Donaldson GC; Perera WR; Wilkinson TM; Bilello JA; Hagan GW; Vessey RS; Wedzicha JA
    Am J Respir Crit Care Med; 2006 Oct; 174(8):867-74. PubMed ID: 16799074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease.
    Ruiz-González A; Lacasta D; Ibarz M; Martínez-Alonso M; Falguera M; Porcel JM
    Respirology; 2008 Nov; 13(7):1028-33. PubMed ID: 18945322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.
    Bozinovski S; Hutchinson A; Thompson M; Macgregor L; Black J; Giannakis E; Karlsson AS; Silvestrini R; Smallwood D; Vlahos R; Irving LB; Anderson GP
    Am J Respir Crit Care Med; 2008 Feb; 177(3):269-78. PubMed ID: 18006888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory changes, recovery and recurrence at COPD exacerbation.
    Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
    Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD).
    Corsonello A; Pedone C; Battaglia S; Paglino G; Bellia V; Incalzi RA
    Arch Gerontol Geriatr; 2011; 53(2):190-5. PubMed ID: 21074870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
    Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
    Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
    Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
    Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
    Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
    Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease.
    Tofan F; Rahimi-Rad MH; Rasmi Y; Rahimirad S
    Pneumologia; 2012; 61(3):160-2. PubMed ID: 23175870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
    Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
    Hurst JR; Perera WR; Wilkinson TM; Donaldson GC; Wedzicha JA
    Am J Respir Crit Care Med; 2006 Jan; 173(1):71-8. PubMed ID: 16179639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.
    Grolimund E; Kutz A; Marlowe RJ; Vögeli A; Alan M; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
    COPD; 2015 Jun; 12(3):295-305. PubMed ID: 25230352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
    Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
    Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
    Komnata K
    Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
    Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
    Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.